Cite
MLA Citation
Peter Taylor et al.. “O02 The JAK1-selective inhibitor filgotinib reverses the disease-associated transcriptional profile in the blood of patients with active rheumatoid arthritis.” Rheumatology, vol. 58, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100092359398.0x000011